The US Court of Appeals for the Federal Circuit on Sept. 28 set aside a decision of the US district court of New Jersey in Newark, reversing the district court’s earlier...
Fujifilm Irvine Scientific, part of Japan’s Fujifilm Holdings, will acquire Shenandoah Biotechnology, a US-based, privately held manufacturer of recombinant proteins...
Asia-Pacific contract research organization (CRO) Novotech has acquired NCGS, a US CRO with about 300 employees and a biopharma client base. Financial terms of the...
Amgen is beefing up its inflammatory diseases portfolio with an agreement to buy US biopharma ChemoCentryx for roughly $3.7 billion. The deal gives Amgen access to...
Alexion, AstraZeneca's rare disease division, has agreed to buy a portfolio of preclinical gene therapy programs and enabling technologies from competitor Pfizer for up...
05.11.2015
- French pharmaceutical producer Sanofi and German biotech firm BioNTech have agreed a multi-year exclusive collaboration and license agreement aimed at leveraging their respective...
28.10.2010
- Danish-listed biotech Genmab is vulnerable to a takeover due to its current low share price, and the company needs more time to develop its full potential, its chief executive told...
Former Millipore executive Dominique Baly, has assumed cross-divisional management of marketing, sales and service for the Sartorius laboratory business as president of...
10.07.2013
- GlaxoSmithKline plans to exploit new technology from private British biotech company Immunocore to develop next-generation drugs against cancer that fight tumors in ways antibody...
05.06.2014
- Adaptimmune, a biotechnology company developing TCR engineered T-cells to treat cancer, has begun a strategic collaboration and licensing agreement with GlaxoSmithKline (GSK) for...